|
ENDV Endonovo Therapeutics Inc 1528172 |
| Balance Sheet |
|
Current Assets
|
$35,504.00 |
|
Assets
|
$815,764.00 |
|
Current Liabilities
|
$23,696,070.00 |
|
Liabilities
|
$23,775,895.00 |
|
Equity
|
$-22,960,131.00 |
|
Shares Out
|
318751597.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-404,363.00 |
| Market Analysis |
Market Cap
|
$191.00 |
|
PB
|
0.31 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-10-01 09:32:04 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-10-26 10:00:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENDV documents filed with the SEC.
ENDV Filings
Clear
